Victory Capital Management
INFI

Victory Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Victory Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,649
Closed -$7K – 2806
2022
Q2 		$7K Sell
11,649
-61
-0.5% -$47 ﹤0.01% 2670
2022
Q1 		$9K Sell
11,710
-463
-4% -$553 ﹤0.01% 2687
2021
Q4 		$27K Sell
12,173
-337
-3% -$846 ﹤0.01% 2678
2021
Q3 		$43K Sell
12,510
-761
-6% -$2.35K ﹤0.01% 2697
2021
Q2 		$40K Buy
13,271
+120
+0.9% +$380 ﹤0.01% 2680
2021
Q1 		$42K Buy
13,151
+3,040
+30% +$10.1K ﹤0.01% 2679
2020
Q4 		$21K Buy
+10,111
New +$16.7K ﹤0.01% 2502
2020
Q2 		– Sell
-18,704
Closed -$16K – 3472
2020
Q1 		$16K Buy
+18,704
New +$21.7K ﹤0.01% 3185
2019
Q4 		– Sell
-9,635
Closed -$10K – 3457
2019
Q3 		$10K Buy
+9,635
New +$13.1K ﹤0.01% 3275

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management's INFI Position: Q3 2022 in Review

Victory Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 11,649 shares — an estimated $7K sold.

Victory Capital Management first reported a position in INFI in Q3 2019 and held it in 9 quarters. The position peaked at $43K in Q3 2021. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Victory Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 11,649 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $7K.
  • Victory Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2019 and held it in 9 quarters.
  • Victory Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $43K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.